Literature DB >> 22797737

The expanding role of civil society in the global HIV/AIDS response: what has the President's Emergency Program For AIDS Relief's role been?

Alex Coutinho1, Uchechi Roxo, Henry Epino, Alex Muganzi, Emily Dorward, Billy Pick.   

Abstract

Civil society has been part of the HIV/AIDS response from the very beginning of the epidemic, often becoming engaged before national governments. Traditional roles of civil society--advocacy, activism, serving as government watchdog, and acting as community caretaker--have been critical to the response. In addition, civil society organizations (CSOs) play an integral part in providing world-class HIV prevention and treatment services and helping to ensure continuity of care. The President's Emergency Program for AIDS Relief (PEPFAR) has significantly increased the global scale-up of combination antiretroviral therapy reaching for more than 5 million people in developing countries, as well as implementation of effective evidence-based combination prevention approaches. PEPFAR databases in 5 countries and annual reports from a centrally managed initiative were mined and analyzed to determine the numbers and types of CSOs funded by PEPFAR over a 5-year period (2006-2011). Data are also presented from Uganda showing the overall resource growth in CSO working for HIV. Case studies document the evolution of 3 indigenous CSOs that increased the capacity to implement activities with PEPFAR funding. A legacy of PEPFAR has been the growth of civil society to address social and health issues as well as recognition by governments that partnerships with beneficiaries and civil society result in better outcomes. Scale-up of the global response could not have happened without the involvement of civil society and people living with HIV. This game changing partnership to jointly tackle the problems that countries face may well be the greatest benefit emerging from the HIV epidemic.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797737     DOI: 10.1097/QAI.0b013e31825d0383

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  3 in total

1.  Institutional Arrangements for Providing HIV and AIDS Services in Uganda: A Transaction Cost Economics Analysis.

Authors:  Sarah Khanakwa; Josue Mbonigaba
Journal:  Health Serv Insights       Date:  2022-05-09

2.  Key informant perspectives on the challenges and opportunities for using routine health data for decision-making in Senegal.

Authors:  Pierre Muhoza; Haneefa Saleem; Adama Faye; Ibrahima Gaye; Roger Tine; Abdoulaye Diaw; Alioune Gueye; Almamy Malick Kante; Andrea Ruff; Melissa A Marx
Journal:  BMC Health Serv Res       Date:  2021-06-22       Impact factor: 2.655

3.  The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: should we ask patients to contribute to the cost of their care?

Authors:  Tom Kakaire; Walter Schlech; Alex Coutinho; Richard Brough; Rosalind Parkes-Ratanshi
Journal:  BMC Public Health       Date:  2016-08-27       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.